CorTec GmbH develops implants for long‑term measurement and stimulation of brain activity and operates the CorTec Brain Interchange (BIC) technology platform as a wireless interface between the brain and an external computer. The system is designed for closed‑loop applications, enables measurement and demand‑based stimulation in real time, and uses electrodes that can be employed for both sensing and stimulation. CorTec is active in the two business areas BIC therapy development and BIC technology and markets its solutions to academic research partners and industry customers in the main markets USA, Asia and Europe. In April 2024 the company implemented a strategic shift toward a CDMO business model focused on revenue from components and supporting customers across the entire product lifecycle.
Die Entwicklung, klinische Testung und Vermarktung von Produkten im Bereich der Neurotechnologie, insbesondere Elektroden und Implantate für das Gehirn.
Converted using the official Destatis and Eurostat correspondence tables; ISIC Rev. 4 is the United Nations' international industry classification.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) Freiburg Local Court, HRB 705960 (as of 31 October 2026)
| Name | Type | City |
|---|---|---|
| Oliver Bärtl | Geschäftsführer(in) | Sipplingen |
| Frank Desiere | Geschäftsführer(in) | Risch |
| Martin Schüttler | Geschäftsführer(in) | Emmendingen |
Source: German Commercial Register (Handelsregister) Freiburg Local Court, HRB 705960 (as of 31 October 2026)
| Date | Event Type | Event |
|---|---|---|
| 20.12.2022 | Gesellschaftsvertrag amended | Gesellschaftsvertrag |
| 06.04.2022 | Gesellschaftsvertrag amended | Gesellschaftsvertrag |
| 23.10.2019 | Gesellschaftsvertrag amended | Gesellschaftsvertrag |
| Date | Type | Change | Total Capital |
|---|---|---|---|
| 20.12.2022 | Capital Increase | +1.035 € | 162.971 € |
| 06.04.2022 | Capital Increase | +4.398 € | 161.936 € |
| 23.10.2019 | Capital Increase | +60.794 € | 157.538 € |
Source: German Commercial Register (Handelsregister) Freiburg Local Court, HRB 705960 (as of 31 October 2026)
| Year | Revenue | Profit | Balance | Employees |
|---|---|---|---|---|
| 2024 | Rohergebnis€6M2 | -€3,030,111 | €17,038,368 | 58 |
| 2023 | Rohergebnis€5.8M2 | -€3,991,928 | €15,833,104 | 33 |
| 2022 | Rohergebnis€3.3M2 | -€6,173,346 | €11,669,660 | 72 |
| 2021 | Rohergebnis€2.6M2 | -€5,670,707 | €3,995,569 | 71 |
| 2020 | Rohergebnis€2.9M2 | -€4,830,858 | €6,157,382 | 65 |
| 2019 | Rohergebnis€3.7M2 | -€3,944,918 | €7,280,046 | 54 |
| 2018 | small company1 | -€2,702,645 | €3,487,879 | 46 |
| 2017 | small company1 | -€1,604,686 | €3,378,628 | 37 |
| 2016 | small company1 | -€1,302,120 | €2,038,265 | 31 |
| 2015 | small company1 | -€893,049 | €911,527 | — |
1 Small companies are not required to publish a profit-and-loss statement (§ 326 (1) HGB). The figure shown is the statutory ceiling under § 267 HGB where the balance-sheet total makes it binding — a company may exceed at most one of the three size criteria.
2 Rohergebnis nach § 276 HGB: Umsatzerlöse abzüglich Materialaufwand bzw. Herstellungskosten. Kleine und mittelgroße Kapitalgesellschaften dürfen diese Posten zusammenfassen; die Umsatzerlöse selbst sind dann nicht veröffentlicht und liegen über dem Rohergebnis.
Sign in to download data
Source: German Commercial Register (Handelsregister) Freiburg Local Court, HRB 705960 (as of 31 October 2026)
HZDR Innovation GmbH
Dresden · Forschung und Entwicklung im Bereich Biotechnologie
EURICE European Research and Project Office GmbH
St. Ingbert · Sonstige Forschung und Entwicklung im Bereich Natur-, Ingenieur-, Agrarwissenschaften und Medizin
IKT - Institut für Unterirdische Infrastruktur gGmbH
Gelsenkirchen · Sonstige Forschung und Entwicklung im Bereich Natur-, Ingenieur-, Agrarwissenschaften und Medizin
| Cost type | Amount | Share |
|---|---|---|
| Personnel Costs | €5,308,333 | 88.6% |
| Depreciation | €148,623 | 2.5% |
| Interest & Similar | €533,023 | 8.9% |
